ATNFW U.S.: Nasdaq

    180 Life Sciences Corp. Wt

    Last Updated: Oct 27, 2021 3:46 p.m. EDT Delayed quote

    $ 0.99

    -0.04 -3.87%
    Previous Close
    Advanced Charting
    Volume: 36.16K 65 Day Avg: 52.28K
    69% vs Avg
    0.98 Day Range 1.03
    0.12 52 Week Range 2.97

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ATNFW Overview


    5 Day
    • -5.47%
    1 Month
    • 7.63%
    3 Month
    • -34.86%
    • 200.03%
    1 Year
    • 377.16%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 1 Full Ratings

    Recent News

    No Headlines Available

    No Headlines Available

    180 Life Sciences Corp. Wt

    180 Life Sciences Corp. develops pharmaceuticals for chronic pain and inflammatory diseases. It operates as a clinical-stage biotechnology company focused on the development of novel drugs that fulfil unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded on September 7, 2016 and is headquartered in Palo Alto, CA.